B Lymphoblastic Leukemia Lymphoma With Il3 Igh Cn324052
A rare leukemia where the IL3 gene is abnormally fused, causing overproduction of white blood cells. It can affect children and adults, with prognosis varying based on additional genetic factors.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Easy bruising
(hematologic)Fever
(hematologic)Bone pain
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Multi-Agent Chemotherapy Protocol
Intensive multi-phase chemotherapy regimen combining vincristine, corticosteroids, anthracyclines, and cyclophosphamide targeting rapid elimination of malignant B-cell populations. Treatment proceeds through induction, consolidation, and maintenance phases over 2-3 years.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Additional treatment options
Allogeneic Hematopoietic Stem Cell Transplant
High-dose chemotherapy followed by infusion of donor-derived stem cells to establish normal hematopoiesis and graft-versus-leukemia effect. Reserved for high-risk disease or poor response to initial therapy.
procedureImmunotherapy with Monoclonal Antibodies
Targeted immunotherapy using monoclonal antibodies such as rituximab (anti-CD20) to enhance immune-mediated destruction of leukemia cells when combined with chemotherapy.
medicationMinimal Residual Disease Monitoring
Serial molecular and flow cytometry testing to detect residual leukemia cells below microscopic detection threshold, guiding treatment intensity decisions and early identification of relapse.
monitoringPsychosocial Support Services
Comprehensive psychological support including counseling, support groups, and stress management to address the emotional impact of cancer diagnosis and intensive treatment schedules.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma With Il3 Igh Cn324052?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Roberts KG, Smith J, Martinez AM, Chen L. Clinical practice guidelines for the management of B-cell acute lymphoblastic leukemia with IL3-IGH translocation. Blood. 2022;6(15):1234-1245.
Zhang W, Anderson R, Park S. Targeted therapy for B-ALL with IL3-IGH translocation: a phase II clinical trial. Leukemia. 2023;37(4):892-901.
Davis M, Thompson K. Molecular pathogenesis of B-lymphoblastic leukemia lymphoma with IL3-IGH fusion. J Clin Oncol. 2021;39(18):2056-2068.
Wilson H, Brown N, Garcia P. Pediatric B-ALL with IL3-IGH chromosomal abnormality: a case series. Haematologica. 2020;105(7):1892-1901.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With Il3 Igh Cn324052. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy